Register | Log in | FAQ      [?] 
Recent | Unread | Search | Authors | Tags | Export

djmonstermo's Furst [6 articles]

Recent papers posted to djmonstermo's library by the author Furst. You can also see everyone's Furst.
  • Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.
    Annals of internal medicine, Vol. 130, No. 6. (16 March 1999), pp. 478-486.
    by LW Moreland, MH Schiff, SW Baumgartner, EA Tindall, RM Fleischmann, KJ Bulpitt, AL Weaver, EC Keystone, DE Furst, PJ Mease, EM Ruderman, DA Horwitz, DG Arkfeld, L Garrison, DJ Burge, CM Blosch, ML Lange, ND McDonnell, ME Weinblatt
    posted to anti-tnf rheum by djmonstermo on 2008-07-20 04:46:49 as **
  • Cyclophosphamide versus placebo in scleroderma lung disease.
    The New England journal of medicine, Vol. 354, No. 25. (22 June 2006), pp. 2655-2666.
    by DP Tashkin, R Elashoff, PJ Clements, J Goldin, MD Roth, DE Furst, E Arriola, R Silver, C Strange, M Bolster, JR Seibold, DJ Riley, VM Hsu, J Varga, DE Schraufnagel, A Theodore, R Simms, R Wise, F Wigley, B White, V Steen, C Read, M Mayes, E Parsley, K Mubarak, MK Connolly, J Golden, M Olman, B Fessler, N Rothfield, M Metersky,
    posted to scleroderma by djmonstermo on 2008-07-19 17:04:55 as **
  • Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosis.
    Annals of the rheumatic diseases, Vol. 66, No. 12. (December 2007), pp. 1641-1647.
    by PJ Clements, MD Roth, R Elashoff, DP Tashkin, J Goldin, RM Silver, M Sterz, JR Seibold, D Schraufnagel, RW Simms, M Bolster, RA Wise, V Steen, MD Mayes, K Connelly, M Metersky, DE Furst,
    posted to scleroderma by djmonstermo on 2008-07-19 17:03:21 as **
  • Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2006.
    Annals of the rheumatic diseases, Vol. 65 Suppl 3 (November 2006)
    by DE Furst, FC Breedveld, JR Kalden, JS Smolen, GR Burmester, P Emery, EC Keystone, MH Schiff, PL van Riel, ME Weinblatt, MH Weisman
    posted to rheum by djmonstermo on 2008-07-19 14:13:41 as **
  • Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group.
    Lancet, Vol. 354, No. 9194. (4 December 1999), pp. 1932-1939.
    by R Maini, EW St Clair, F Breedveld, D Furst, J Kalden, M Weisman, J Smolen, P Emery, G Harriman, M Feldmann, P Lipsky
    posted to anti-tnf rheum by djmonstermo on 2008-07-18 03:39:12 as **
  • Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.
    The New England journal of medicine, Vol. 343, No. 22. (30 November 2000), pp. 1594-1602.
    by PE Lipsky, DM van der Heijde, EW St Clair, DE Furst, FC Breedveld, JR Kalden, JS Smolen, M Weisman, P Emery, M Feldmann, GR Harriman, RN Maini,
    posted to anti-tnf rheum by djmonstermo on 2008-07-18 03:32:49 as **
    • Note: You may cite this page as: http://www.citeulike.org/user/djmonstermo/author/Furst

    RIS BibTeX
    CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.